S

Sequana Medical NV
SEQUA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€54.45M
EV
€90.76M
Shares Outstanding
52.87M
Beta
-0.02

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€3.97
P/E 2025E
-
P/Revenue 2025E
88.17x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Sequana Medical NV

gainify

S

Sequana Medical NV

SEQUA

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump sy...

Sector

Healthcare

Industry

Medical - Devices

CEO

Crosbie, Ian

Employees

48

IPO Date

2019-02-11

Headquarters

Kortrijksesteenweg 1112, box 102, Sint-Denijs-Westrem, Gent, East Flanders, 9051, Belgium

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved